The magnetic resonance imaging (MRI) market is worth USD 6.47 billion in 2025 and is anticipated to register USD 9.76 billion by 2035. The market is poised to expand at a 4.2% CAGR during the forecast period. Growth is being driven by increasing demand for high-precision diagnostic imaging in neurology, oncology, and cardiovascular applications.
MRI systems offer non-invasive, radiation-free scanning capabilities that allow for early disease detection, anatomical visualization, and long-term monitoring. Rising chronic disease incidence, coupled with an aging global population, is propelling investment in MRI infrastructure across hospitals, specialty clinics, and diagnostic chains. Additionally, healthcare systems in emerging markets are scaling up imaging capacities, supporting a steady rise in equipment procurement and service integration.
Product innovation and digital transformation are further accelerating MRI market momentum. Leading imaging firms are investing in high-field (3T and 7T) systems, silent MRI technologies, portable scanners, and AI-integrated imaging platforms. These developments are streamlining workflows, reducing scan times, and improving diagnostic accuracy. AI-enabled MRI solutions are also being deployed for real-time image analysis, workflow automation, and enhanced diagnostic insights particularly in high-volume radiology settings.
The rise of mobile imaging units and remote interpretation technologies is expanding MRI access across rural and semi-urban regions. Favorable reimbursement frameworks for outpatient imaging and preventive diagnostics are helping improve patient access, while also encouraging hospitals to upgrade legacy systems with newer, AI-powered models.
Moreover, the MRI market is likely to benefit from evolving regulatory frameworks that support innovation while prioritizing safety and quality. Agencies such as the USA, FDA, European EMA, and Japan’s PMDA have established stringent performance standards for high-field and AI-enabled MRI systems. Governments are also updating imaging reimbursement policies and pushing for interoperability and data privacy compliance.
Global regulatory initiatives are promoting the adoption of digital diagnostics through standardized imaging protocols, post-market surveillance, and cybersecurity safeguards. As diagnostic imaging becomes central to personalized care, the MRI market is likely to experience increased adoption, particularly in health systems emphasizing early intervention, value-based care, and digital integration.
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 6.47 billion |
| Industry Value (2035F) | USD 9.76 billion |
| CAGR (2025 to 2035) | 4.2% |
The market is segmented based on product, field strength, application, end user, and region. By product, the market is divided into open systems and closed systems. In terms of field strength, it is segmented into low field strength, mid field strength, and high field strength.
Based on application, the market is categorized into neurology, cardiology, gastroenterology, musculoskeletal, body imaging, and other applications including oncology imaging, breast imaging, pediatric imaging, and vascular imaging.
In terms of end user, the market includes hospitals, ambulatory surgical centers, and others such as diagnostic imaging centers, research institutes, academic medical centers, and specialty clinics. Regionally, the market is classified into North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe, and the Middle East and Africa.
Closed MRI systems are projected to hold a 68.5% share of the global MRI market in 2025, maintaining their status as the preferred diagnostic modality across hospitals and imaging centers. These systems are valued for delivering high-resolution imaging with deep tissue penetration, making them indispensable in neurological, musculoskeletal, oncological, and cardiovascular evaluations.
Their ability to operate at high field strengths typically 1.5T and 3T enables faster scan times and clearer anatomical visualization, crucial for time-sensitive and complex clinical cases. Urban hospitals and academic institutions continue to favor closed systems for their throughput efficiency and integration with AI-assisted imaging protocols, including automated lesion detection and image reconstruction tools.
Conversely, open MRI systems are becoming increasingly attractive for niche demographics including pediatric, geriatric, and claustrophobic patients. Their open architecture design enhances patient comfort and reduces scan anxiety, making them suitable for outpatient settings and orthopedic diagnostics.
Technological advancements such as motion correction algorithms, improved radiofrequency coils, and AI-driven image enhancement are significantly closing the gap in image quality. These improvements are expanding their clinical applicability and positioning open systems as viable alternatives for targeted imaging procedures. The open system segment captures 31.5% share.
| Product | Share (2025) |
|---|---|
| Closed MRI Systems | 68.5% |
| Open MRI Systems | 31.5% |
High-field MRI systems are projected to grow at the highest CAGR of 6.1% from 2025 to 2035, driven by rising demand for precision diagnostics in neurology, oncology, and cardiovascular care. These systems, typically operating at 1.5T and above, offer superior signal-to-noise ratios and advanced imaging capabilities, enabling early detection of subtle abnormalities.
High-field scanners are increasingly adopted in academic hospitals and tertiary care centers, where complex cases require sharper resolution and multi-sequence protocols. Integration with AI-based imaging tools, functional MRI, and spectroscopy is further enhancing their diagnostic value across a range of clinical specialties.
The high-field MRI systems segment accounts for 45% share. Mid-field MRI systems continue to serve as the backbone of routine imaging, particularly in general hospitals and outpatient facilities. With field strengths generally between 0.3T and 1.0T, they strike a balance between image quality and affordability.
These systems are widely used for musculoskeletal, abdominal, and neurological scans and remain popular for day-to-day diagnostic workflows. Their lower acquisition and maintenance costs make them ideal for providers in cost-sensitive markets or facilities with limited space and technical support. As healthcare systems work to expand MRI access without compromising efficiency, mid-field scanners are expected to retain a strong presence, especially in mid-tier and regional healthcare networks. The mid-field segment occupies 22% share.
| Field Strength | Share (2025) |
|---|---|
| High-Field MRI Systems | 45% |
| Mid-Field MRI Systems | 22% |
The neurology segment is projected to grow at the highest CAGR of 6.5% from 2025 to 2035, supported by rising cases of neurological disorders such as stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. This segment registers 43% share. MRI remains the gold standard for brain and spinal imaging due to its superior contrast resolution, non-invasive nature, and ability to detect subtle lesions and vascular anomalies.
The growing elderly population, increased stroke awareness, and access to advanced neuroimaging are driving investments in MRI systems optimized for neurological use. Integration of functional MRI (fMRI) and diffusion tensor imaging (DTI) into clinical workflows is further boosting neurology’s role in MRI demand. Musculoskeletal imaging holds significant clinical relevance in orthopedics, particularly for evaluating ligament tears, cartilage degeneration, and joint injuries.
Cardiovascular and gastrointestinal applications are also expanding steadily with advancements in cardiac MRI and MR enterography. Oncology remains a key growth area for MRI applications, as cancer screening and treatment planning increasingly depend on precise anatomical and functional imaging.
MRI is being widely adopted in detecting tumors in the brain, breast, liver, and prostate, with clinicians relying on its high-resolution, radiation-free output to guide personalized and minimally invasive cancer therapies. Moreover, the cardiology segment holds 28% share.
| Application | Share (2025) |
|---|---|
| Neurology | 43% |
| Cardiology | 28% |
Hospitals are expected to dominate the end user segment, accounting for 61.3% of total MRI installations in 2025, driven by their capacity to handle high patient volumes and offer full-spectrum diagnostic services. These institutions prioritize comprehensive imaging solutions for neurological, cardiovascular, orthopedic, and oncological care, integrating MRI with surgical and therapeutic workflows.
Tertiary and multi-specialty hospitals continue to invest in high-field and AI-assisted MRI systems to improve diagnostic precision and workflow efficiency. Additionally, the ability to support inpatient and outpatient care in a single facility makes hospitals the cornerstone of MRI utilization worldwide.
Ambulatory surgical centers and academic medical institutions also play a growing role in market demand, especially where elective imaging and research applications are prominent. Diagnostic imaging centers are emerging as the fastest-expanding end user group, supported by rising demand for decentralized, patient-friendly imaging services.
These facilities provide faster scheduling, lower operational costs, and targeted diagnostic offerings across urban and semi-urban regions. As healthcare systems shift toward value-based care and outpatient diagnostics, standalone imaging centers are investing in compact, AI-integrated MRI systems to enhance accessibility, improve throughput, and meet the growing need for non-invasive, precision-based diagnostics. The ambulatory surgical centers segment accounts for 34% share.
| End User | Share (2025) |
|---|---|
| Hospitals | 61.3% |
| Ambulatory Surgical Centers | 34% |
Continuous innovations in MRI equipment, such as the development of higher-field strength machines (e.g., 3T and 7T MRI), functional MRI (fMRI), and hybrid imaging systems (like PET/MRI), have significantly improved image quality, diagnostic accuracy, and patient comfort. These advancements enable more precise detection and characterization of diseases, making MRI an indispensable tool in modern diagnostics.
The rising incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders drives the demand for advanced diagnostic imaging. MRI is particularly valuable in these areas due to its non-invasive nature and superior ability to differentiate between soft tissues, aiding in early diagnosis and treatment planning.
The global aging population is a significant driver for the MRI market. Elderly individuals are more susceptible to chronic illnesses and degenerative conditions that require frequent and detailed imaging for effective management. As life expectancy increases, the demand for magnetic resonance imaging procedures is expected to rise correspondingly.
Growing awareness about the benefits of early diagnosis and preventive healthcare has led to an increase in routine screening programs. MRI’s non-ionizing radiation makes it a preferred choice for repeated scans and monitoring, particularly in vulnerable populations such as children and pregnant women.
The expanding range of MRI applications beyond traditional uses, such as in cardiology, oncology, and musculoskeletal imaging, fuels the market growth of MRI systems. Innovations like functional MRI (fMRI) and diffusion tensor imaging (DTI) are opening new avenues in brain mapping and cognitive neuroscience, further broadening MRI's utility.
Investments in healthcare infrastructure, especially in emerging economies, enhance the availability and accessibility of advanced diagnostic tools like MRI. Government initiatives and private sector investments in building new healthcare facilities and upgrading existing ones contribute to the increased adoption of MRI technology.
The MRI market in the United States is characterized by robust demand driven by several key factors. Firstly, the country's advanced healthcare infrastructure and high healthcare spending contribute significantly to the widespread adoption of MRI technology.
With a substantial number of medical facilities equipped with MRI machines, including hospitals, clinics, and diagnostic centers, accessibility to MRI services is widespread across the nation. Moreover, the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions underscores the importance of MRI in early diagnosis and treatment planning.
As the aging population continues to grow, the demand for MRI machines is expected to further escalate, given the indispensable role MRI plays in diagnosing age-related ailments like Alzheimer's disease. Additionally, continuous technological advancements in MRI technology, such as higher resolution imaging and faster scanning techniques, drive healthcare providers to upgrade their equipment regularly, further stimulating market demand.
Overall, the United States maintains a dominant position in the global MRI market, characterized by high market penetration, technological innovation, and a strong demand for advanced medical imaging services.
In the United Kingdom, the demand for MRI is influenced by the National Health Service (NHS) policies and funding. The NHS provides widespread access to healthcare services, including MRI scans, which are integral to the diagnosis and management of various medical conditions.
The United Kingdom has seen a growing need for MRI due to an increase in chronic illnesses such as cancer and cardiovascular diseases, alongside a rising elderly population.
Government initiatives to reduce waiting times for diagnostic procedures and improve healthcare outcomes have led to investments in MRI technology and infrastructure. Furthermore, public awareness campaigns emphasizing early detection and preventive health measures contribute to the increased demand for MRI services in the United Kingdom.
In India, the MRI market is experiencing rapid expansion, fueled by various socioeconomic and healthcare-related factors. Increasing infrastructure investment, coupled with technological advancements in MRI systems, demand for MRI machines is on the rise.
India's large and diverse population, coupled with improving standards of living and rising disposable incomes, has led to greater awareness about preventive healthcare measures and early disease detection, driving the uptake of MRI services.
Moreover, medical tourism has emerged as a key driver of the MRI market in India, with the country attracting patients from neighboring countries seeking affordable and high-quality medical services, including advances in diagnostic imaging technology.
Government initiatives aimed at improving healthcare access in rural areas and tier-2 cities have also spurred demand for MRI machines beyond urban centers. Technological advancements, such as the development of low-cost MRI systems tailored to the needs of the Indian market, further facilitate market growth by addressing affordability challenges.
Overall, India presents a lucrative opportunity for MRI manufacturers and service providers, given its vast market potential, supportive regulatory environment, and evolving healthcare landscape.
MRI manufacturers are continually investing in research and development to introduce innovative technologies that improve imaging quality, enhance patient comfort, and increase operational efficiency.
Companies are forming strategic partnerships and collaborations with healthcare providers, research institutions, and technology companies to leverage complementary expertise, access new markets, and accelerate product development.
These partnerships may involve co-development of new imaging technologies, joint research initiatives, or distribution agreements to expand market reach.
| Attribute | Details |
|---|---|
| Current Total Market Size (2025) | USD 6.47 billion |
| Projected Market Size (2035) | USD 9.76 billion |
| CAGR (2025 to 2035) | 4.2% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Report Parameter | USD billion for value and million units for volume |
| By Product Type | Open Systems and Closed Systems |
| By Field Strength | Low Field Strength, Mid Field Strength, and High Field Strength |
| By Application | Neurology, Cardiology, Gastroenterology, Musculoskeletal, Body Imaging, Other Applications (Oncology Imaging, Breast Imaging, Pediatric Imaging, Vascular Imaging) |
| By End User | Hospitals, Ambulatory Surgical Centers, Others (Diagnostic Imaging Centers, Academic Medical Centers, Research Institutes, Specialty Clinics) |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia, Middle East and Africa |
| Countries Covered | United States, United Kingdom, France, Germany, Japan |
| Key Players | Siemens Healthcare GmbH, Koninklijke Philips N.V., Toshiba Corporation, GE Healthcare, Hitachi Medical Systems, Esaote SpA, Sanrad Medical Systems Pvt. Ltd., Aurora Imaging Technologies, Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, AllTech Medical Systems |
| Additional Attributes | Dollar sales by value, market share analysis by region, and country-wise analysis |
In terms of product, the market includes open system and closed system.
The field strength segment includes low-field strength, mid-field strength, and high field strength.
Based on application the industry is segmented into neurology, cardiology, gastroenterology, musculoskeletal, body imaging, and other applications.
In terms of end user, the market is segmented into hospitals, ambulatory surgical centers and others.
As per region, the industry is divided into North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe, and the Middle East and Africa.
The global MRI market is expected to reach USD 9.76 billion by 2035, up from USD 6.47 billion in 2025, expanding at a CAGR of 4.2% during the forecast period.
Closed MRI systems are anticipated to hold a 68.5% share of the market in 2025 due to their superior imaging performance, deep tissue penetration, and widespread use in clinical diagnostics across hospitals and imaging centers.
High-field MRI systems, operating at 1.5T and above, are forecasted to grow at the highest CAGR of 6.1% from 2025 to 2035, driven by increased demand for precision imaging in neurology and oncology.
The neurology segment is projected to grow at a CAGR of 6.5% through 2035, as MRI remains essential for detecting brain and spinal disorders including stroke, multiple sclerosis, and neurodegenerative diseases.
Key players include Siemens Healthcare GmbH, GE Healthcare, Philips, Canon Medical Systems Corporation, and Fujifilm Holdings Corporation, all of which are advancing AI-enabled, high-field MRI technologies.
Explore Diagnostic Devices Insights
Magnetic Resonance Imaging (MRI) Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
